COVID-19 Vaccine - EOI Update John Baillie

COVID-19 Vaccine - EOI Update John Baillie
1 / 1
COVID-19 Vaccine - EOI Update John Baillie - slide 1 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 2 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 3 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 4 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 5 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 6 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 7 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 8 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 9 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 10 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 11 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 12 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 13 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 14 of 15 COVID-19 Vaccine - EOI Update John Baillie - slide 15 of 15
COVID-19 Vaccine - EOI Update John Baillie Executive Manager HNECC PHN WE ACKNOWLEDGE THE TRADITIONAL OWNERS CUSTODIANS OF THE LAND THAT WE LIVE WORK ON AS THE FIRST PEOPLE OF THIS COUNTRY. These slides will be circulated after the

Related Topics

Download this presentation From Below

"COVID-19 Vaccine - EOI Update John Baillie" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Presentation Transcript

01
COVID-19 Vaccine - EOI
Update
John Baillie
Executive Manager HNECC PHN

WE ACKNOWLEDGE THE TRADITIONAL OWNERS & CUSTODIANS OF THE LAND THAT WE LIVE & WORK ON AS THE FIRST PEOPLE OF THIS COUNTRY.<br>
02
These slides will be circulated after the webinar

Key local contacts

John Baillie jbaillie@hneccphn.com.au 0439944123

Kimberly Booth kbooth@hneccphn.com.au

Potential applicants can seek clarification on this EOI by sending an email to
primarycareCOVIDvaccine@health.gov.au

Questions and responses will be shared with all potential applicants if relevant/appropriate<br>
03
Vaccine status

COVID-19 vaccines COMIRNATY (BNT162b2[mRNA]) COVID-19 Vaccine (known as COMIRNATY (BNT162b2[mRNA]) COVID-19 Vaccine) now provisionally approved, with a rollout to priority groups in Phase 1a commencing mid / late February
(Fully imported - Note: competitive international market at play)


OXFORD / Astra Zeneca TGA approval expected by the end of this month, with a rollout to priority groups in Phase 1b – 2b
(Manufactured on shore = not so influenced by international markets)


MODERNA/ NOVAVAX /COVAX and others later in the year<br>